EP 2137216 A2 20091230 - USE OF EPHB4 AS A DIAGNOSTIC MARKER AND A THERAPEUTIC TARGET FOR OVARIAN CANCER
Title (en)
USE OF EPHB4 AS A DIAGNOSTIC MARKER AND A THERAPEUTIC TARGET FOR OVARIAN CANCER
Title (de)
VERWENDUNG VON EPHB4 ALS DIAGNOSTISCHER MARKER UND THERAPEUTISCHES ZIEL FÜR EIERSTOCKKREBS
Title (fr)
UTILISATION DU RÉCEPTEUR EPHB4 COMME MARQUEUR DIAGNOSTIQUE ET CIBLE THÉRAPEUTIQUE DANS LE CANCER DE L'OVAIRE
Publication
Application
Priority
- US 2008003355 W 20080312
- US 90676407 P 20070312
- US 90672707 P 20070312
Abstract (en)
[origin: WO2008112290A2] In certain embodiments, this present invention provides compositions, and methods for inhibiting EphB4 activity in ovarian cancer. In other embodiments, the present invention provides methods and compositions for treating ovarian cancer.
IPC 8 full level
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 16/00 (2006.01); C12N 15/113 (2010.01)
CPC (source: EP)
A61P 9/00 (2017.12); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12); C07K 16/2866 (2013.01); C12N 15/1138 (2013.01); G01N 33/57449 (2013.01); A61K 2039/505 (2013.01); C07K 2317/73 (2013.01); C07K 2317/75 (2013.01); C07K 2317/76 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/315 (2013.01); G01N 2333/715 (2013.01)
Citation (search report)
See references of WO 2008112290A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2008112290 A2 20080918; WO 2008112290 A3 20081231; AU 2008226824 A1 20080918; CA 2703136 A1 20080918; CN 101932604 A 20101229; EP 2137216 A2 20091230; JP 2010521467 A 20100624
DOCDB simple family (application)
US 2008003355 W 20080312; AU 2008226824 A 20080312; CA 2703136 A 20080312; CN 200880015097 A 20080312; EP 08726797 A 20080312; JP 2009553630 A 20080312